Iquix

Iquix is a brand name of levofloxacin ophthalmic, approved by the FDA in the following formulation(s):

IQUIX (levofloxacin - solution/drops; ophthalmic)

• 
  Manufacturer: SANTEN
  
  Approval date: March 1, 2004
  
  Strength(s): 1.5% ^[RLD]

Has a generic version of Iquix been approved?

No. There is currently no therapeutically equivalent version of Iquix available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Iquix. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Iquix.

See also...

• Iquix Drops Consumer Information (Wolters Kluwer)
• Iquix Advanced Consumer Information (Micromedex)
• Levofloxacin Drops Consumer Information (Wolters Kluwer)
• Levofloxacin Eye Drops Consumer Information (Wolters Kluwer)
• Levofloxacin ophthalmic Consumer Information (Cerner Multum)
• Levofloxacin Ophthalmic Advanced Consumer Information (Micromedex)
• Levofloxacin eent AHFS DI Monographs (ASHP)